An elevated triglyceride-glucose index predicts adverse outcomes and interacts with the treatment strategy in patients with three-vessel disease.
Zhang Y, Zhang C, Jiang L, Xu L, Tian J, Zhao X, Wang D, Zhang Y, Sun K, Zhang C, Xu B, Zhao W, Hui R, Gao R, Wang J, Feng X, Yuan J, Song L.
Zhang Y, et al. Among authors: hui r.
Cardiovasc Diabetol. 2023 Dec 6;22(1):333. doi: 10.1186/s12933-023-02063-4.
Cardiovasc Diabetol. 2023.
PMID: 38057801
Free PMC article.